Drag a card by its title · ⚙ to size, swap or remove

The company

Processa Pharmaceuticals, Inc.

PCSA · Nasdaq

Health CareBiotechnologyNot moving yet

PCSA stood above a rising 150-day average in 3 of the last 52 weekly readings, and has been out of that trend for the last 44 weeks. It is 27.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 44
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $450K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 12 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 3 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months45

Sale orders, 12 months0

Buyers · sellers9 · 0

Who	Did	Shares	Traded
George K. NgChief Executive Officer	bought	3,057at $1.93	1 Jul 2026filed 1 Jul 2026
David YoungPres. Research & Development	bought	2,531at $1.93	30 Jun 2026filed 1 Jul 2026
Russell SkibstedChief Financial Officer	bought	3,277at $1.93	30 Jun 2026filed 1 Jul 2026
Patrick LinChief Business - Strategy Off	bought	2,106at $1.93	30 Jun 2026filed 1 Jul 2026
Wendy GuyChief Administrative Officer	bought	2,436at $1.93	30 Jun 2026filed 1 Jul 2026
Wendy GuyChief Administrative Officer	bought	2,118at $2.22	15 Jun 2026filed 16 Jun 2026
Patrick LinChief Business - Strategy Off	bought	1,831at $2.22	15 Jun 2026filed 16 Jun 2026
George K. NgChief Executive Officer	bought	2,465at $2.22	15 Jun 2026filed 16 Jun 2026
Russell SkibstedChief Financial Officer	bought	2,654at $2.22	15 Jun 2026filed 16 Jun 2026
David YoungPres. Research & Development	bought	2,067at $2.22	15 Jun 2026filed 16 Jun 2026
Wendy GuyChief Administrative Officer	bought	1,829at $2.57	29 May 2026filed 1 Jun 2026
Patrick LinChief Business - Strategy Off	bought	1,582at $2.57	29 May 2026filed 1 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders12+2 on the quarter

New · exited4 · 2

Reported value$498K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Connective Capital Management, LLCadded · filed 13 Aug 2026	85,274$164K	+14,538+20.6%
Stonepine Capital Management, LLCunchanged · filed 14 Aug 2026	55,000$106K	00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	22,090$42K	-2,818−11.3%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026	21,306$41K	+21,306
XTX Topco Ltdnew · filed 14 Aug 2026	13,292$26K	+13,292
JANE STREET GROUP, LLCnew · filed 14 Aug 2026	13,264$25K	+13,264
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026	12,729$24K	00.0%
StoneX Group Inc.new · filed 12 Aug 2026	11,437$30K	+11,437
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026	10,857$21K	00.0%
UBS Group AGadded · filed 13 Aug 2026	7,794$15K	+5,263+207.9%